Form 4: Marpai Inc. Director Mohsen Moazami Sells 15,000 Shares

Director Mohsen Moazami sold 15,000 shares of Marpai Inc. (MRAI) at $0.6788 per share on May 29, 2024, leaving him with 35,000 shares.

Summary

• On May 29, 2024, Mohsen Moazami, a director of Marpai, Inc. (MRAI), sold 15,000 shares of Class A Common Stock.
• The sale price was $0.6788 per share.
• Following the transaction, Moazami directly owns 35,000 shares of Marpai, Inc.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of insider trading. The impact depends on the broader context of the company's performance and market conditions.

Negatives

• A director selling shares could be perceived negatively by investors.

Risks

• Insider selling can sometimes signal a lack of confidence in the company's future prospects, potentially impacting investor sentiment.

Industry Context

This transaction is a routine disclosure of insider trading activity. It's important to monitor such filings in conjunction with overall company performance and industry trends to assess potential implications.

Comparison to Industry Standards

• Insider trading activity is common and closely monitored across publicly traded companies.
• Comparing this transaction to similar insider sales at comparable companies in the healthcare technology sector could provide context.
• For example, monitoring Form 4 filings of directors at companies like Teladoc Health or Accolade could offer a benchmark.

Stakeholder Impact

• Shareholders may react to the news of a director selling shares, potentially influencing the stock price.

Key Dates

Keywords

Marpai Inc., MRAI, Mohsen Moazami, Director, Share Sale, Insider Trading, Form 4, SEC Filing